279 related articles for article (PubMed ID: 30114440)
1. The role of T cells in the pathogenesis of Parkinson's disease.
Chen Z; Chen S; Liu J
Prog Neurobiol; 2018 Oct; 169():1-23. PubMed ID: 30114440
[TBL] [Abstract][Full Text] [Related]
2. T-Cell-Driven Inflammation as a Mediator of the Gut-Brain Axis Involved in Parkinson's Disease.
Campos-Acuña J; Elgueta D; Pacheco R
Front Immunol; 2019; 10():239. PubMed ID: 30828335
[TBL] [Abstract][Full Text] [Related]
3. Neuroinflammation is a key player in Parkinson's disease and a prime target for therapy.
Qian L; Flood PM; Hong JS
J Neural Transm (Vienna); 2010 Aug; 117(8):971-9. PubMed ID: 20571837
[TBL] [Abstract][Full Text] [Related]
4. Innate and adaptive immune responses in Parkinson's disease.
Schonhoff AM; Williams GP; Wallen ZD; Standaert DG; Harms AS
Prog Brain Res; 2020; 252():169-216. PubMed ID: 32247364
[TBL] [Abstract][Full Text] [Related]
5. Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson's disease.
Williams GP; Schonhoff AM; Jurkuvenaite A; Thome AD; Standaert DG; Harms AS
J Neuroinflammation; 2018 Aug; 15(1):244. PubMed ID: 30165873
[TBL] [Abstract][Full Text] [Related]
6. Neural and immune mechanisms in the pathogenesis of Parkinson's disease.
Blandini F
J Neuroimmune Pharmacol; 2013 Mar; 8(1):189-201. PubMed ID: 23378275
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the Neurodegenerative Process Associated to Parkinson's Disease by CD4+ T-cells.
González H; Contreras F; Pacheco R
J Neuroimmune Pharmacol; 2015 Dec; 10(4):561-75. PubMed ID: 26018603
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration.
Qin H; Buckley JA; Li X; Liu Y; Fox TH; Meares GP; Yu H; Yan Z; Harms AS; Li Y; Standaert DG; Benveniste EN
J Neurosci; 2016 May; 36(18):5144-59. PubMed ID: 27147665
[TBL] [Abstract][Full Text] [Related]
10. Neuroinflammation in Parkinson's disease.
Hirsch EC; Vyas S; Hunot S
Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S210-2. PubMed ID: 22166438
[TBL] [Abstract][Full Text] [Related]
11. Parkinson's disease: Autoimmunity and neuroinflammation.
De Virgilio A; Greco A; Fabbrini G; Inghilleri M; Rizzo MI; Gallo A; Conte M; Rosato C; Ciniglio Appiani M; de Vincentiis M
Autoimmun Rev; 2016 Oct; 15(10):1005-11. PubMed ID: 27497913
[TBL] [Abstract][Full Text] [Related]
12. Neuroinflammation in Parkinson's disease: a target for neuroprotection?
Hirsch EC; Hunot S
Lancet Neurol; 2009 Apr; 8(4):382-97. PubMed ID: 19296921
[TBL] [Abstract][Full Text] [Related]
13. Neuroinflammation in Parkinson's disease: role in neurodegeneration and tissue repair.
Vivekanantham S; Shah S; Dewji R; Dewji A; Khatri C; Ologunde R
Int J Neurosci; 2015; 125(10):717-25. PubMed ID: 25364880
[TBL] [Abstract][Full Text] [Related]
14. New Insights into Immune-Mediated Mechanisms in Parkinson's Disease.
Tan JSY; Chao YX; Rötzschke O; Tan EK
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291304
[TBL] [Abstract][Full Text] [Related]
15. The Trojan horse - neuroinflammatory impact of T cells in neurodegenerative diseases.
Sommer A; Winner B; Prots I
Mol Neurodegener; 2017 Oct; 12(1):78. PubMed ID: 29078813
[TBL] [Abstract][Full Text] [Related]
16. Neuroinflammation in Parkinson's disease animal models: a cell stress response or a step in neurodegeneration?
Cebrián C; Loike JD; Sulzer D
Curr Top Behav Neurosci; 2015; 22():237-70. PubMed ID: 25293443
[TBL] [Abstract][Full Text] [Related]
17. Defining the contribution of neuroinflammation to Parkinson's disease in humanized immune system mice.
Manocha GD; Floden AM; Puig KL; Nagamoto-Combs K; Scherzer CR; Combs CK
Mol Neurodegener; 2017 Feb; 12(1):17. PubMed ID: 28196514
[TBL] [Abstract][Full Text] [Related]
18. Neuroinflammation in Parkinson's disease.
Lee JK; Tran T; Tansey MG
J Neuroimmune Pharmacol; 2009 Dec; 4(4):419-29. PubMed ID: 19821032
[TBL] [Abstract][Full Text] [Related]
19. Inflammation in Parkinson's Disease: Mechanisms and Therapeutic Implications.
Pajares M; I Rojo A; Manda G; Boscá L; Cuadrado A
Cells; 2020 Jul; 9(7):. PubMed ID: 32674367
[TBL] [Abstract][Full Text] [Related]
20. The key role of T cells in Parkinson's disease pathogenesis and therapy.
Baird JK; Bourdette D; Meshul CK; Quinn JF
Parkinsonism Relat Disord; 2019 Mar; 60():25-31. PubMed ID: 30404763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
